Alar Pharmaceuticals Inc. (6785)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
98. 80
-2.2
-2.1782%
NT$
- Market Cap
8.62 P/E Ratio
184% Div Yield
46,937 Volume
0 Eps
NT$ 101
Previous Close Want to track 6785 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alar Pharmaceuticals Inc. (6785) Statistics
Valuation metrics
Market Cap -
Enterprise value 4.77B
Trailing P/E (ttm) -58
Forward P/E -
PEG ratio 0.95
Price/Sales (ttm) 2,193.3
Price/Book (mrq) 2.78
Enterprise Value/Revenue 1,587.95
Enterprise Value/EBITDA -26.38
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 87.3K
Average volume (90 days) 94.2K
Price summary
52-Week low 92
52-Week high 317
Beta -
50-Day moving average 111.46
200-Day moving average 158.27
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.25
Trailing annual dividend yield 0.002%
5-Year annual dividend yield -
Payout ratio -0.15
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 26 Jun 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -37.55%
Operating margin -62.91%
Operational effectiveness
Return on assets -0.05%
Return on equity -0.05%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.69
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 34.48
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 25.01%
Book value per share (mrq) 35.45
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
